Glucarpidase Approved to Lower Toxic Chemotherapy Levels in the Blood
Last week, the Food and Drug Administration (FDA) approved glucarpidase (Voraxaze) to treat patients with toxic levels of the chemotherapy methotrexate (Abitrexate) in their blood.
NCI Cancer Bulletin
This digital document is an article from NWHRC Health Center – Colon Cancer, published by Thomson Gale on September 7, 2006. The l…
IBS – Irritable Bowel Syndrome Understanding Signs, Symptoms, Causes & Diets of IBSIBS – Irritable Bowel SyndromeUnderstanding Signs, Symptoms, Causes & Diets of IBS. Topics included:What Is Irritable Bowel Syndro…
The Embarrassing Truth About Crohn’s Disease AND How To Cure ItThe Embarrassing Truth About Crohn’s Disease AND How To Cure It is available on Kindle or you can download it to your computer wit…
Categories: Colon Cancer Causes Tags: Approved, blood, Chemotherapy, Glucarpidase, Levels, Lower, toxic
Keppra® Approved By FDA For Childhood Seizures
In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approved to lower the age restriction to include infants from the age of one month and older with epilepsy. Professor Dr. Iris Loew-Friedrich, Chief Medical Officer and Executive Vice President UCB â�¨declared: â�¨”As a leader in epilepsy UCB has a responsibility to develop effective medicines that address unmet medical needs…
Health News from Medical News Today
This digital document is an article from Internal Medicine News, published by Thomson Gale on May 15, 2006. The length of the arti…
This digital document is an article from NWHRC Health Center – Colon Cancer, published by Thomson Gale on September 7, 2006. The l…
Students, researchers, and patients can find reliable, up-to-date and clearly written information in “The Gale Encyclopedia of C…
Categories: Colon Cancer Drugs Tags: Approved, childhood, Keppra®, Seizures
Ruxolitinib Approved to Treat the Bone Marrow Disease Myelofibrosis
On November 16, the Food and Drug Administration (FDA) approved ruxolitinib (Jakafi) for patients with intermediate- or high-risk myelofibrosis. Ruxolitinib is the first drug approved specifically to treat patients with this bone marrow disease.
NCI Cancer Bulletin
21st Century Understanding Cancer Toolkit: Cancer Causes and Prevention, Cancer and the Environment, Comprehensive Coverage of Specific Risk Factors and Prevention by Type and Organ SystemThis massive compendium, with over 500 pages and fifty chapters, has authoritative information and practical advice from the natio…
Complementary/Holistic Medicine for Colon Cancer – It’s Your Life, Live It!As an Oncology Nurse. I had only one protocol in mind while writing this book. That was to show you the most successful alternativ…
What You Need to Know About Colon Cancer – It’s Your Life, Live It!As an Oncology Nurse. I had only one protocol in mind while writing this book. That was to show you the most successful cancer tre…
Dark Blue Ribbon Bracelet-Survivor (Retail)This is a beautiful dark blue ribbon bracelet. Each one has sterling silver charms that say hope, faith love with pretty dark blu…
Categories: Colon Cancer Causes Tags: Approved, Bone, Disease, marrow, Myelofibrosis, Ruxolitinib, Treat
New Form of Asparaginase Approved to Treat Acute Lymphoblastic Leukemia
On November 18, the Food and Drug Administration (FDA) approved Erwinaze, an alternate form of asparaginase that is derived from the bacterium Erwinia chrysanthemi, to treat acute lymphoblastic leukemia (ALL) in patients who have become allergic (hypersensitive) to other forms of asparaginase derived from the bacterium Escherichia coli.
NCI Cancer Bulletin
Dark Blue Ribbon Bracelet-Survivor (Retail)This is a beautiful dark blue ribbon bracelet. Each one has sterling silver charms that say hope, faith love with pretty dark blu…
The Cure for All Cancers: Including over 100 Case Histories of Persons CuredCancer can now be cured, not just treated We are not accustomed to thinking about a cure for cancer. We think of remission as the …
This digital document is an article from NWHRC Health Center – Colon Cancer, published by Thomson Gale on September 7, 2006. The l…
Categories: Colon Cancer Causes Tags: Acute, Approved, Asparaginase, form, Leukemia, Lymphoblastic, Treat
Cetuximab Approved for Patients with Advanced Head and Neck Cancer
The Food and Drug Administration (FDA) last week approved the targeted drug cetuximab (Erbitux), in combination with chemotherapy, for the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck.
NCI Cancer Bulletin
Liver Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages. Everything You Need to Know About Liver CancerLiver Cancer: This book is for people who have liver cancer, as well as for their family members, friends, students, and others wh…
Symptoms Of Colon CancerWe all know, life has a way of throwing things at us, diseases is one of them. Most times it comes at a bad time, even though its …
21st Century Understanding Cancer Toolkit: Cancer Causes and Prevention, Cancer and the Environment, Comprehensive Coverage of Specific Risk Factors and Prevention by Type and Organ SystemThis massive compendium, with over 500 pages and fifty chapters, has authoritative information and practical advice from the natio…
Hemacord – First Cord Blood Product Approved By FDA
The FDA has approved HEMACORD, the first cord blood product ever to be approved in the USA. It used in hematopoietic stem cell transplantation procedures for individuals with disorders affecting the blood-forming system – known as the hematopoietic system. Potential patients include those with some kinds of blood cancers, as well as people with inherited metabolic and immune system disorders. Karen Midthun, M.D…
Health News from Medical News Today
This digital document is an article from Internal Medicine News, published by International Medical News Group on June 1, 2003. Th…
This digital document is an article from Internal Medicine News, published by International Medical News Group on August 1, 2009. …
IRESSA-A boon to colon cancer: In-silico studies on Iressa drug inhibiting Epidermal growth factor receptor(EGFR) involved in colon cancerThe epidermal growth factor receptor (EGFR) is under investigation as a therapeutic target for cancers. Colon cancer cell lines ar…
Bone Density Drug Approved for Prostate and Breast Cancer Patients
The Food and Drug Administration (FDA) has approved the use of denosumab (Prolia, Xgeva) to increase bone mass in two groups of patients at high risk for fractures: men receiving androgen deprivation therapy for nonmetastatic prostate cancer and women receiving an aromatase inhibitor as post-surgical or adjuvant therapy for breast cancer.
NCI Cancer Bulletin
What You Need to Know About Colon Cancer – It’s Your Life, Live It!As an Oncology Nurse. I had only one protocol in mind while writing this book. That was to show you the most successful cancer tre…
IBS – Irritable Bowel Syndrome Understanding Signs, Symptoms, Causes & Diets of IBSIBS – Irritable Bowel SyndromeUnderstanding Signs, Symptoms, Causes & Diets of IBS. Topics included:What Is Irritable Bowel Syndro…
Complementary/Holistic Medicine for Rectal Cancer – It’s Your Life, Live It!As an Oncology Nurse. I had only one protocol in mind while writing this book. That was to show you the most successful alternativ…
Categories: Colon Cancer Causes Tags: Approved, Bone, Breast, Cancer, Density, Drug, Patients, prostate
Xalkori Approved For Late-stage Lung Cancer In Patients With Abnormal ALK Gene
The US FDA has approved Xalkori (crizotinib) for the treatment of late-stage NSCLC (non-small cell lung cancer) in patients who have the abnormal ALK (anaplastic lymphoma kinase) gene. Patients undergo a genetic test, known as the Vysis ALK Break Apart FISH Probe Kit which detects the abnormal gene. The FDA has also approved this test. The abnormal ALK gene causes cancer to develop and grow…
Cancer / Oncology News From Medical News Today
Categories: Colon Cancer Foundation Tags: abnormal, Approved, Cancer, Gene, LateStage, Lung, Patients, Xalkori
Development bonds approved for new cancer hospital – Newnan Times-Herald
The Coweta County Development Authority announced at its Thursday meeting the approval of a resolution authorizing the issuance of industrial revenue bonds to assist in the construction of the newest Cancer Treatment Centers of America hospital. “We are …
cancer – Bing News
On The Far Side of The Curve: A Stage IV Colon Cancer Survivor’s JourneyOn the Far Side of the Curve: A Stage IV Colon Cancer Survivor’s Journey is cancer survivor Wayne Cooke’s dramatic and compreh…
How To Protect Against Colon Cancer NaturallyA concise easy to read guide on how to protect yourself from colon cancer by using natural means such as changing your diet and li…
Living with Colon Cancer: Beating the OddsDespite the efforts of Katie Couric to draw attention to the importance of colonoscopy screening for the detection of colon cancer…
Categories: Colon Cancer Tags: Approved, bonds, Cancer, development, HOSPITAL, Newnan, TimesHerald
Triple Vaccine Boostrix Approved For Senior Patients By US FDA
The FDA (US Food and Drug Administration) has approved the triple vaccine “Boostrix” – for tetanus, diphtheria and pertussis (whooping cough) – for individuals aged 65+ years. Boostrix is made by GlaxoSmithKline Biologicals. This is the first triple vaccine for older patients. Before Boostrix’s approval, available multiple vaccines only protected against tetanus and diphtheria. Boostrix is given as a single booster shot. Tetanus – caused by a bacterium that lives in the soil, manure, and dust, it enters the human body usually through a deep cut and paralyses the infected person…
Health News from Medical News Today
Worried Sick: A Prescription for Health in an Overtreated America (H. Eugene and Lillian Youngs Lehman)At a time when access to health care in the United States is being widely debated, Nortin Hadler argues that an even more importan…
This digital document is an article from Internal Medicine News, published by International Medical News Group on September 1, 200…
Chemotherapy – Questions and Answers about Chemotherapy and Cancer Treatments. Everything You Need to Know about ChemotherapyAbout This BookChemotherapy and You is written for you – someone who is about to receive or is now receiving chemotherapy for canc…
